Live Quote · OTCVCNXHealthcare· Biotechnology

Vaccinex, Inc.

$1.02 0.00%(+$0.00)
TickerSpark Score
66/100
Solid
50
Valuation
60
Profitability
80
Growth
40
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VCNX research report →

52-Week Range60% of range
Low
$0.31
Current
$1.02
High
$1.50
Company Overviewwww.vaccinex.com

About the company

Vaccinex, Inc. is a biotechnology firm operating in the clinical stage, dedicated to identifying and developing specialized biological therapies. Its core mission is to address serious medical conditions and diseases that currently lack adequate treatment options.

CEO
Maurice Zauderer
IPO
2018
Employees
23
HQ
Rochester, NY, US

Price Chart

+39.73% · this period
$1.49$0.91$0.34Jul 02Dec 31Jul 02
Valuation
Market Cap
$2.73M
P/E
-0.11
P/S
4.54
P/B
-0.86
EV/EBITDA
-0.09
Div Yield
0.00%
Profitability
Gross Margin
100.00%
Op Margin
-3117.30%
Net Margin
-3100.50%
ROE
776.58%
ROIC
760.66%
Growth & Income
Revenue
$601.00K · 5.44%
Net Income
$-18,634,000 · 7.98%
EPS
$-8.88 · 79.67%
Op Income
$-18,735,000
FCF YoY
6.32%
Performance & Tape
52W High
$1.50
52W Low
$0.31
50D MA
$0.99
200D MA
$0.90
Beta
0.65
Avg Volume
2.49K

Get TickerSpark's AI analysis on VCNX

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Nov 14, 24FRIEDBERG ALBERTother30,756
Nov 14, 24FRIEDBERG ALBERTother584,646
Nov 14, 24Zauderer Mauriceother46,153
Sep 18, 24Zauderer Mauriceother35,715
Sep 18, 24Zauderer Mauriceother9,768
Sep 18, 24Zauderer Mauriceother29,557
Sep 18, 24Zauderer Mauriceother38,610
Sep 18, 24Zauderer Mauriceother170,475
Sep 18, 24Zauderer Mauriceother35,715
Sep 18, 24FRIEDBERG ALBERTother25,723
Coverage · VCNX

Our VCNX coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on VCNX yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate VCNX report →
Internal Compare

Similar companies

Peers in the same neighborhood.